Anti-HIV T cell therapy: Filed IND for a Phase I/II trial

Cell Genesys Inc. (CEGE), Foster City, Calif. Product: Anti-HIV T cell therapy, in which a patient's CD8+ cytotoxic T cells are engineered to express a construct gene consisting of part of the CD4 rec...